American publicly traded medical device company founded in 1927, specializing in orthopedic reconstructive products, sports medicine, spine, and dental solutions.
Company Type
public
Founded
1927
Headquarters
Warsaw, Indiana, USA
Stock
NASDAQ: ZBH
Revenue
$8.5 billion (FY2025)
Employees
~25,000
Primary Market
Global
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. The company operates across multiple product categories including orthopedic reconstructive products (knee, hip, shoulder, elbow), sports medicine and biologics, extremities and trauma products, office-based technologies, and spine and dental solutions.
The company maintains significant research and development operations focused on innovation in musculoskeletal healthcare. Zimmer Biomet's success is built on its ability to develop cutting-edge medical devices, acquire innovative companies, and integrate them into its global distribution and manufacturing network. The company serves hospitals, surgical centers, and healthcare providers worldwide.
Zimmer Biomet traces its origins to 1927 when Zimmer Manufacturing Company was founded to produce orthopedic devices and implants. The company established itself as a leader in orthopedic reconstructive products throughout the 20th century, developing innovative solutions for joint replacement and trauma care.
In 2001, Zimmer merged with Biomet, Inc., a major orthopedic implant manufacturer, creating Zimmer Biomet Holdings. This merger significantly expanded the company's product portfolio and global reach. The combined company became the largest orthopedic device manufacturer in the world, with comprehensive offerings across multiple musculoskeletal healthcare segments.
Since the merger, Zimmer Biomet has pursued an aggressive acquisition strategy to expand into adjacent markets and acquire innovative technologies. Recent acquisitions include Paragon 28 (foot and ankle specialist), OrthoGrid Systems (AI surgical guidance), and Monogram Technologies. In 2024, the company announced plans to spin off its spine and dental business as ZimVie, focusing Zimmer Biomet on orthopedic reconstructive and sports medicine products.
Zimmer Biomet owns 3 brands in our database.

Owned by Zimmer Biomet
American medical device company specializing in surgical instruments and orthopedic tools, acquired by Zimmer Biomet.

Owned by Zimmer Biomet
American medical technology company specializing in AI-powered surgical guidance systems for orthopedic procedures, acquired by Zimmer Biomet.

Owned by Zimmer Biomet
American precision manufacturing company specializing in complex turbomachinery components for aerospace, defense, space, and industrial applications.
Yes, Zimmer Biomet is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ZBH. Investors can purchase shares through stock brokers and investment platforms.
Zimmer Biomet traces its origins to 1927 when Zimmer Manufacturing Company was founded. The modern Zimmer Biomet was formed through the 2001 merger of Zimmer Holdings and Biomet, Inc.
Zimmer Biomet is headquartered in Warsaw, Indiana, USA, where the company maintains its corporate offices and primary operations.
Zimmer Biomet manufactures orthopedic reconstructive products, sports medicine solutions, trauma devices, extremities products, office-based technologies, and dental and spine implants. The company also recently acquired Paragon 28 (foot and ankle) and OrthoGrid Systems (AI surgical guidance).
Major brands include Zimmer Biomet (primary brand), Biomet, Paragon 28, OrthoGrid Systems, and Monogram Technologies. The company also spun off ZimVie in 2024 to focus on spine and dental products.
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.

American multinational conglomerate specializing in diagnostics, life sciences, environmental and applied solutions, and product identification.
10 brands in portfolio

American healthcare technology company spun off from General Electric in 2023, known for medical imaging, diagnostics, and healthcare IT solutions, headquartered in Chicago, Illinois.
3 brands in portfolio

American aerospace and industrial company providing advanced engineered solutions including jet engine components, fastening systems, titanium structures, and forged aluminum wheels.
1 brand in portfolio

American consumer health company specializing in over-the-counter health and wellness products, spun off from Johnson & Johnson.
4 brands in portfolio

American motion and control technologies company founded in 1917, known for hydraulic, pneumatic, and electromechanical components, headquartered in Cleveland, Ohio.
2 brands in portfolio

American global pharmaceutical company formed in 2020 through the merger of Upjohn and Mylan, known for generic and brand-name medicines, headquartered in Canonsburg, Pennsylvania.
4 brands in portfolio